Featured Jobs
|
Daybright Financial
|
|
The Pension Source
|
|
Daybright Financial
|
|
MAP Retirement
|
|
MAP Retirement
|
|
MAP Retirement
|
|
Senior Counsel – Investment Solutions Great Gray Trust Company
|
|
Nova 401(k) Associates
|
|
Regional Vice President, Sales MAP Retirement
|
|
The MandMarblestone Group, llc
|
|
Senior Retirement Plan Administrator (TPA) Public Accounting Firm
|
|
Retirement Relationship Manager MAP Retirement
|
|
Participant Support Representative Daybright Financial
|
|
Senior Plan Consultant, Defined Benefit DWC - The 401(k) Experts
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Policy Strategies for Aligning Price and Value for Brand-Name Pharmaceuticals
Health Affairs 
Mar. 16, 2018 "To achieve the difficult balance between necessary incentives for innovation and affordability, many economists favor 'value-based' pricing, in which the price for a new drug reflects an assessment of the comparative effectiveness of the drug compared to other available treatments. [This brief explores] the different varieties of value-based pricing, and [outlines] several measures through which drug competition may be increased, supported by regulatory steps and payment mechanisms to bring drug prices into greater alignment with their underlying clinical value." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |